SUD Monitoring Expansion Averhealth specializes in substance use disorder monitoring and treatment, with a 20+ year track record, presenting an upsell opportunity to expand monitoring services beyond current clients or to migrate integrated collections, lab services, and results reporting to a unified platform for new health plans or employer programs.

Integrated Services Strength Current model covers collections, laboratory services, and results reporting. Sales can target organizations seeking end-to-end SUD monitoring solutions, offering bundled services that streamline compliance, reduce vendor management overhead, and improve turnaround times for results.

Public Sector Partnerships Recent news indicates partnerships with government and educational institutions (Washoe County courts, SJDC). This suggests a favorable trajectory for expanding into court systems, correctional facilities, and public sector programs that require reliable monitoring and reporting infrastructure.

Growth Through Acquisition Averhealth previously acquired Aspenti and is backed by five Arrows Capital Partners, signaling an appetite for strategic growth. This indicates potential for cross-selling to Aspenti clients or leveraging capital to scale sales initiatives and geographic reach.

Mid-market Focus With 201-500 employees and a revenue range of 10M-25M, Averhealth sits in the mid-market segment. This presents a target for mid-sized health plans, employers, and integrated care providers seeking scalable SUD monitoring solutions with predictable pricing and service levels.